Sort
21,281 grants matching “influenza”
Vaccine strategies that target cytolic CD4 T cells to the lung.
$216,873Deborah M Brown · University Of Nebraska Lincoln · R21 · FY2011 · AI
Integrating health and biology in a science curriculum for Latino preschoolers
$216,853Laura F Romo · University Of California Santa Barbara · R25 · FY2016 · OD
Respiratory Virus Ion Channels
$216,805Lawrence H Pinto · Northwestern University · R01 · FY2006 · AI
Monitoring cause-specific school absences to estimate influenza transmission in W
$216,732Derek A Cummings · Johns Hopkins University · U01 · FY2013 · CK
LA RED NETWORK INFORMATICS TECHNOLOGY SUPPORT TASK ORDER
$216,582Mary Smolskis · Social And Scientific Systems, Inc. · N01 · FY2022 · AI
Human Health and 'Human Bulletins': Scientists and Teens Explore Health Sciences
$216,552Monique Renee Scott · American Museum Of Natural History · R25 · FY2012 · OD
Human Health and 'Human Bulletins': Scientists and Teens Explore Health Sciences
$216,480Monique Renee Scott · American Museum Of Natural History · R25 · FY2010 · RR
DEVELOPING SUSTAINABLE INFLUENZA SURVEILLANCE NETWORKS AND RESPONSE TO AVIAN AND
$216,400Endang Sedyanighsih · Ministry Of Health Republic Of Indonesia · U51 · FY2009 · IP
Fatty Acid Synthase Inhibitors As Broad Spectrum Anti-Flaviviral Therapeutics
$216,374Glenn C Randall · University Of Chicago · R21 · FY2013 · AI
Impact of Pandemic Mitigation Efforts on Colonization and Transmission of Respiratory Pathogens and Antibiotic Resistance Genes
$216,250Leigh Meredith Howard · Vanderbilt University Medical Center · R21 · FY2023 · AI
Development of Biomarkers for Study of Botanical Immunomodulators in Humans
$216,156Barrie R Cassileth · Sloan-Kettering Inst Can Research · P50 · FY2008 · AT
California Emerging Infections Program Capacity Building, Influenza Testing and B
$216,151Arthur L. Reingold · Public Health Foundation Enterprises · U01 · FY2011 · CI
KPT-335 as novel therapeutic for respiratory syncytial virus
$216,133Ralph A Tripp · University Of Georgia · R21 · FY2015 · AI
Characterization of 3rd & 4th dengue virus infections in a pediatric cohort study
$216,127Angel Lazaro Balmaseda · Sustainable Sciences Institute · R01 · FY2015 · AI
Defining the optimal type and timing of COVID-19 vaccine in pregnancy
$216,125Ai-Ris Yonekura Collier · Beth Israel Deaconess Medical Center · R21 · FY2022 · AI
SUPPORTING INFLUENZA VACCINE INTRODUCTION IN LOW-MIDDLE INCOME COUNTRIES
$216,100Nora I Dellepiane · World Health Organization · U01 · FY2013 · FD
A novel assay for inhibitors of influenza A virus polymerase complex assembly
$216,039Feng Li · South Dakota State University · R21 · FY2009 · AI
INTRODUCING THE USE OF SEASONAL INFLUENZA VACCINES
$216,000Tran Dacphu · General Department/ Preventive Medicine · U51 · FY2015 · IP
Peru Infectious Diseases Epidemiology Research Training Consortium
$216,000Andres G Lescano · Naval Medical Research Unit South (Namru South) · D43 · FY2011 · TW
BUNYAVIRUS/MOSQUITO INTERACTIONS
$216,000University Of Wisconsin Madison · R01 · FY2001 · AI
BUNYAVIRUS/MOSQUITO INTERACTIONS
$216,000University Of Wisconsin Madison · R01 · FY2003 · AI
Visualizing Interferon-beta Induction In Vivo
$216,000Mark E. Peeples · Research Inst Nationwide Children'S Hosp · R21 · FY2009 · AI
The NTHI Sap Transporter: A Mechanism of Antimicrobial Peptide Resistance
$216,000Kevin M Mason · Research Inst Nationwide Children'S Hosp · R21 · FY2007 · AI
Secondary infections during mycobacterial disease
$215,975University Of Wisconsin Madison · R21 · FY2003 · AI
Secondary infections during mycobacterial disease
$215,884University Of Wisconsin Madison · R21 · FY2004 · AI